Bortezomib, pertuzumab, thalidomide, trastuzumab and trastuzumab-emtansine are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.
- Bortezomib (Velcade®) is a proteasome inhibitor and is indicated for the treatment of multiple myeloma and mantle cell lymphoma.
- Pertuzumab (Perjeta®) is a monoclonal antibody and is indicated for the treatment of breast neoplasms.
- Thalidomide (Thalidomide Celgene®, Thalomid®) is an immunomodulatory agent and is indicated for the treatment of multiple myeloma.
- Trastuzumab (Herceptin®) is a monoclonal antibody and is indicated for the treatment of breast neoplasms and stomach neoplasms.
- Trastuzumab-emtansine (Kadcyla®) is a monoclonal antibody and is indicated for the treatment of breast neoplasms.
